For the control group, there is no additional medical risk to participating in this study, as they will be receiving the seasonal flu vaccine in the same manner that they would if they were not participating in the study and no supplemental procedure will be necessary except for an observation period of 60 minutes, a follow-up telephone call 24 hours after vaccination and a short medical questionnaire.